Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart transplantation in the Netherlands : A national achievement.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2018
Same author

[Child psychiatry: limited research, evidence for cost-effectiveness of treatment].

Tijdschrift voor psychiatrie·2016
Same author

The diagnosis of left ventricular assist device thrombosis.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Physical training in patients with chronic heart failure: An elaboration of the statements from the Committee on Cardiac Rehabilitation of the Netherlands Society of Cardiology and the Netherlands Heart Foundation and review of studies on physical training in chronic heart failure.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Long-term outcome after heart transplantation performed in the University Medical Centre Groningen.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

The suitability of a single intertidal fish trap for the assessment of long-term trends in fish and epibenthic invertebrate populations.

Environmental monitoring and assessment·2013

Related Experiment Video

Updated: May 5, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 27, 2013

25.1K

Logistical problems in prehospital thrombolysis.

J Brügemann1, J van der Meer, P A de Graeff

  • 1Department of Cardiology, University of Groningen, The Netherlands.

European Heart Journal
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Prehospital thrombolytic treatment for acute myocardial infarction (AMI) using anistreplase was not feasible in a medium-sized town. This approach led to significant time delays and is unlikely to provide clinical benefits.

More Related Videos

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

15.6K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.2K

Related Experiment Videos

Last Updated: May 5, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 27, 2013

25.1K
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

15.6K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.2K

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) requires rapid treatment for optimal outcomes.
  • Thrombolytic therapy is a critical intervention for AMI.
  • Prehospital treatment strategies aim to reduce time to reperfusion.

Purpose of the Study:

  • To compare the efficacy and safety of prehospital versus in-hospital thrombolytic treatment with anistreplase in AMI patients.
  • To assess the feasibility of prehospital thrombolytic administration by paramedics and general practitioners.

Main Methods:

  • A study involving 350 patients screened for chest pain and potential AMI.
  • Inclusion criteria: absence of contraindications and confirmation of AMI via telephone-transmitted ECG.
  • Randomization of eligible patients to either prehospital or in-hospital treatment arms.

Main Results:

  • Only 16 patients (5%) were eligible, with just 7 (2%) randomized over 6 months.
  • Major barriers to inclusion included advanced age, prolonged chest pain duration (>4 hours), and logistical issues.
  • Prehospital ECG procedures significantly increased time spent at home (38 min vs. 14 min).

Conclusions:

  • Prehospital intravenous thrombolytic therapy for AMI is not feasible in a medium-sized town setting.
  • The current prehospital approach leads to unnecessary time delays, negating potential clinical benefits.
  • In-hospital treatment remains the more practical and effective strategy for thrombolysis in AMI.